Surgical management of very early onset inflammatory bowel disease

Sarah J Ullrich1, Annie Le-Nguyen1, Monica Holder1

  • 1Colorectal Center at Cincinnati Children's Hospital, Division of Pediatric General & Thoracic Surgery, 3333 Burnet Ave, Cincinnati, OH 45229, USA.

PubMed

Insights

Surgical intervention is needed in 22% of very early-onset inflammatory bowel disease (VEO-IBD) patients. Factors like Black race, early diagnosis, and disease severity influence the need for surgery in VEO-IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Surgery
  • Inflammatory Bowel Disease Research

Background:

  • Very early-onset inflammatory bowel disease (VEO-IBD) incidence is rising in children under six.
  • VEO-IBD presents unique clinical features, treatment responses, and outcomes.
  • The role of surgical intervention in VEO-IBD remains poorly understood.

Purpose of the Study:

  • To examine the surgical management strategies and outcomes in pediatric patients diagnosed with VEO-IBD.
  • To identify factors associated with the need for surgical intervention in this population.

Main Methods:

  • A retrospective review of 121 VEO-IBD patients diagnosed between January 2008 and May 2024 at a single institution.
  • Data collected included demographics, clinical characteristics, and disease severity.
  • Descriptive statistics were used for data analysis.

Main Results:

  • Crohn's disease was the most common phenotype (61.2%), often affecting the colon (62.8%).
  • Surgical intervention was required in 21.5% of patients, with ostomy creation and bowel resection being common procedures.
  • Black race, diagnosis before one year of age, decreased height velocity, perianal disease, and disease severity were significantly associated with operative intervention.

Conclusions:

  • This study, the largest single-center review, found a 22% surgical intervention rate in VEO-IBD.
  • Key factors influencing surgical need include Black race, age at diagnosis, disease severity, decreased height velocity, and perianal disease.
  • Further research is essential to clarify the role and outcomes of surgery in managing heterogeneous VEO-IBD cases.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
212
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
189
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
202
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540